Cytonics Corp
About Cytonics Corp
Cytonics Corp is a privately held biotechnology company founded in 2006 and headquartered in Jupiter, Florida. It develops regenerative medicine treatments for osteoarthritis, centered on its APIC system that concentrates the A2M blood protein from patients' own blood for injection into damaged joints. The APIC system has treated over 8,000 patients and helped avoid invasive surgeries. The company has financed its programs entirely through equity crowdfunding and NIH grants without traditional VC or pharma backing.
- 🔗 Cytonics Raises $25M through Equity Crowdfunding | Cytonics Corporation posted on the topic | LinkedIn
- 🔗 Cytonics Announces Launch of Regulation A+ Equity Crowdfunding Campaign to Fund Phase 2 Development
- 🔗 Cytonics Announces Launch of Regulation A+ Equity Crowdfunding Campaign to Fund Phase 2 Development
- 🔗 Cytonics Corporation
- 🔗 Investors | Cytonics
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised over $25M via eight equity crowdfunding rounds since 2019 from 7,800+ shareholders
- APIC system commercialized and used to treat over 8,000 osteoarthritis patients
- Received $1.8M in NIH grants to support research
- Advancing Phase 2 development through community-owned financing model
- Maintains independence by avoiding VC, pharma partners, and institutional investors
Ask StreetZero about Cytonics Corp
Put our AI to work on this deal.
Similar companies
Other Crowdfunding deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account